Peak Tricuspid Regurgitation Jet Velocity and Kidney Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
心衰竭伴保留射血分數患者的三尖瓣返流峰值射流速度與腎臟結果的關聯。
Kidney Int Rep 2024-10-21
Association of Estimated Glomerular Filtration Rate Trajectories with Atrial Fibrillation Risk in Populations with Normal or Mildly Impaired Renal Function.
正常或輕度腎功能受損人群中,估計腎小管過濾率變化與心房顫動風險的關聯。
Kidney Dis (Basel) 2024-08-12
Cardiac and kidney outcomes after sacubitril-valsartan therapy: recovery of cardiac function relative to kidney function decline.
Sacubitril-valsartan 治療後的心臟和腎臟結果:心臟功能恢復相對於腎功能下降的情況。
Kidney Res Clin Pract 2024-10-10
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of 4 Trials.
心衰竭中的收縮壓和脈壓:四項試驗的參與者層級綜合分析。
J Am Coll Cardiol 2025-01-02
這項研究探討基線收縮壓(SBP)和脈壓(PP)對心臟衰竭患者(輕度減少或保留射血分數)心血管結果的影響。雖然目前建議將SBP目標設定為<130 mm Hg,但支持證據有限。研究分析了近17,000名患者的數據,結果顯示SBP與心血管風險之間存在J形關係,120-130 mm Hg時風險最低,而PP在50-60 mm Hg時風險也最低。研究強調在管理HFmrEF/HFpEF患者時,應謹慎考量SBP和PP目標,過度降低SBP可能反而增加風險。
PubMedDOI
Heart failure subphenotypes based on mean arterial pressure trajectory identify patients at increased risk of acute kidney injury.
基於平均動脈壓軌跡的心臟衰竭亞表型可識別出急性腎損傷風險增加的患者。
Ren Fail 2025-01-20
Case Series Evaluating the Relationship of SGLT2 Inhibition to Pulmonary Artery Pressure and Non-Invasive Cardiopulmonary Parameters in HFpEF/HFmrEF Patients-A Pilot Study.
評估 SGLT2 抑制與 HFpEF/HFmrEF 患者肺動脈壓及非侵入性心肺參數之關係的案例系列研究 - 一項初步研究。
Sensors (Basel) 2025-02-13